Last autumn, Barcelona hosted the CPhI Worldwide for the first time, and it was a record-breaking year for the event. In their article, Nuria Pelaez, …

We are at the beginning of a new age in cancer therapy. With a large and growing number of patents and applications in this space, …

The forthcoming ISO IDMP standards governing pharmaceutical product information recording have far-reaching implications for the way companies capture, collate, organise and report a very wide …

Globalisation and the growing efforts to standardise submission requirements and formats internationally continue to open up new markets for life sciences companies. Yet, there are …

In her piece, Rosalie Harrison, an International Management Consultant with Borderless, addresses the benefits of inclusion & diversity. She tells us that inclusion is the …

Petra Botzem and Dr Thomas Hille of LTS Lohmann answer this provoking question in their paper on the ICH guideline Q8, with focus on Transdermal …

The combination of advanced molecular force fields and improved visualisation capabilities has enabled chemists to expand their ligand-only view of the electrostatics of their system …

The development of biological therapeutics has led to remarkable clinical benefits in many indications. But, despite this success, the induction of anti-drug antibodies (ADAs) due …

Needle-free injection technology has evolved significantly over the last 50 years and is now accepted in many routine immunisation settings as a safe and effective …

New solutions are proliferating to improve the efficiency of the clinical research function within pharmaceutical companies and CROs. In her article, Theodora Sarver of Almac …